Events - Past
Topics covered in this workshop include the Unix shell, version control with git, and Programming with Python. Read more “2-Day Python Workshop 2/1-2/2018 Gables Campus”
Awards & Honors
CCS Vizualization program director Alberto Cairo has been selected as the 2018 recipient of the Majeri Award for Graphics Journalism from Ball State University’s Department of Journalism. Read more “Alberto Cairo receives Majeri Award for Graphics Journalism”
Events - Past
Join us for the inaugural meeting of the Spatial+ Data Visualization Group. The mission of the Spatial+ Data Visualization Group is to provide GIS and Visualization professionals, educators, enthusiasts, and other users with opportunities to exchange information and ideas, share best practices, and stay up to date with the latest tools, approaches, and more. Read more “Spatial+ Data Visualization Inaugural Meeting 2/23/2018”
Events - Past
Many of the current developments in Precision Oncology refer to the major role played by data. Big data resources (DB, repositories, biobanks, etc.) and novel data types combine in integrative experimental research settings presenting a variety of complexities. These require nextgen computational tools to be derived from the emerging data science field. Read more “BBSR Precision Oncology Workshop 2/26/2018”
News - Archived
The Global Women in Data Science (WiDS) Conference aims to inspire and educate data scientists worldwide, regardless of gender, and support women in the field. This annual Conference is held at Stanford University and 100+ locations worldwide, hosted by WiDSAmbassadors. Read more “WiDS Conference 3/5/2018”
Events - Past
The 2nd annual Smart Cities Miami Conference (2018), presented by Hotwire Communications, explored the convergence of technology, design, and development in the shaping of a new urban landscape transformed by design innovation and disruptive technology. Read more “Smart Cities 2018 Presented by HotWire”
Events - Past
On March 2nd, 2018, the University of Miami hosted the first Data Intersections symposium. The goal of Data Intersections is to enable a conversation between professionals and scholars from domains that have been deeply transformed by the increasing availability of data and the digital tools used to manipulate it, such as data science, statistics, data journalism, the physical and biological sciences, and the digital humanities. Read more “Data Intersections Symposium 2018”
News - Archived
Ontology sounds a lot like a medical specialty—but it’s not related to Oncology, Otolaryngology, or Ophthalmology—except that researchers organizing Big Data in Biomedicine into different ‘ontologies’ or categories could help expedite new drug targets and discoveries in these specialties, and others, in the future.
The University of Miami Miller School of Medicine is joining a partnership to combine advances in ontologies, templates, and other research tools to take digital biomedical research data to the next level. Read more “Public-Private Partnership to Facilitate Ontology Use and Application”
News
If you build it, the data will not only come, it will be standardized, accessible, and reusable by researchers around the world. With this in mind, the National Institutes of Health (NIH) is creating its Data Commons initiative, and recently invited University of Miami investigators to contribute their expertise. “There is a big effort at the NIH now to bring biomedical research into the data science era. Data science including machine learning is all around us—like recommendation engines for shopping or movies, image and voice recognition, language translation, even the news you see on social media, and your personalized internet search results,” said Stephan Schürer, PhD, Program Director, Drug Discovery, and Associate Professor of Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. Read more “IDSC joins International NIH Data Commons Consortium”
News
It’s part genomics*, part big data, and all about driving discoveries that could someday translate to new treatments for cancer, neurological diseases, addiction, and many other conditions, said Stephan Schürer, Ph.D., CCS Drug Discovery program director, and associate professor of molecular and cellular pharmacology at the UM Miller School of Medicine.
The NIH’s “Illuminating the Druggable Genome“ (IDG) initiative is expected to generate a lot of scientific information from several investigators at leading institutions nationwide. Schürer has been appointed to the IDG’s Resource Dissemination and Outreach Center to organize the incoming data and coordinate project resources. Read more “Genomics meets Big Data in Illuminating the Druggable Genome”